0001437749-24-018626.txt : 20240529
0001437749-24-018626.hdr.sgml : 20240529
20240529175953
ACCESSION NUMBER: 0001437749-24-018626
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240524
FILED AS OF DATE: 20240529
DATE AS OF CHANGE: 20240529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stengone Carmine N.
CENTRAL INDEX KEY: 0001861519
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42001
FILM NUMBER: 241000015
MAIL ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Contineum Therapeutics, Inc.
CENTRAL INDEX KEY: 0001855175
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 271467257
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 333-5280
MAIL ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Pipeline Therapeutics, Inc.
DATE OF NAME CHANGE: 20210405
4
1
rdgdoc.xml
OPTION GRANT
X0508
4
2024-05-24
0001855175
Contineum Therapeutics, Inc.
CTNM
0001861519
Stengone Carmine N.
10578 SCIENCE CENTER DRIVE, SUITE 200
SAN DIEGO
CA
92121
1
1
CEO and President
0
Stock Option (right to buy)
15.76
2024-05-24
4
A
0
285000
0
A
2034-05-23
Class A Common Stock
285000
285000
D
Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on April 5, 2025, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.
/s/ Peter Slover, Attorney-in-Fact
2024-05-29